JAKing up hematopoietic proliferation
- 30 April 2005
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 7 (4), 291-293
- https://doi.org/10.1016/j.ccr.2005.04.002
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisCancer Cell, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Focus on myeloproliferative diseases and myelodysplastic syndromesCancer Cell, 2004
- JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem CellsCell, 2004
- Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesisBlood, 2004
- Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemiaNature Genetics, 2003
- Cytokine Signaling in 2002Cell, 2002
- Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− MiceCell, 1999
- Expression of Bcl-x in Erythroid Precursors from Patients with Polycythemia VeraNew England Journal of Medicine, 1998